AzTrials
AzTrials

Deep CariesPhase 4NCT03568474

Silver Diamine Fluoride After Minimal Caries Removal Technique in Asymptomatic Young Permanent Teeth With Deep Caries

A Phase 4 study testing Silver Diamine Fluoride and Glass Ionomer in people with Deep Caries, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is comparing between the Silver Diamine Fluoride after minimal caries removal versus glass ionomer in permanent teeth with open apex Read more about this study

Who is it for?
Ages 6 to 9 yearsHealthy volunteers can take part
Conditions the study is for
Deep Caries
What is being tested?
Silver Diamine Fluoride and Glass Ionomer
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
Oct 2018to Apr 2020
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 9 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Patients free from any systematic diseases.
  • Young permanent molars with incompletely formed roots having deep carious lesions according to clinical and radiographic examination and at risk of pulp exposure if complete caries is removed.
  • Absence of clinical pathologic signs (fistula, swelling and abnormal tooth mobility)
  • The absence of clinical symptoms of irreversible pulpitis.
  • Absence of adverse radiographic findings (interradicular or periapical radiolucencies, thickening of the periodontal space, internal and external root resorption).
  • Compliant patient/ parent.

Who cannot join

  • Teeth with previous restorative treatment.
  • Unrestorable teeth.
  • Uncooperative patients.

Trial locations and contacts

No sites are listed yet.

Sara A Mahmoud, PhD contact

+201000042564

sara_yn79@yahoo.com

About this study

Official title: Postoperative Pain After Application of Silver Diamine Fluoride and Glass Ionomer Versus Glass Ionomer Alone Following Minimal Caries Removal Technique in Asymptomatic Young Permanent Teeth With Deep Caries. A Randomized Pilot Study.

This study is comparing between the Silver Diamine Fluoride after minimal caries removal versus glass ionomer in permanent teeth with open apex

Read the detailed description

The study will be carried on young permanent molars with open apices \& with deep caries. Incomplete caries removal and application of indirect pulp capping materials where Silver Diamine Fluoride (Group I) will be compared with glass ionomer only (group II). Then final restoration with composite resin for both groups. Children will be followed up for 9 months.

Conditions
Deep Caries
Being tested
Silver Diamine Fluoride, Glass Ionomer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Silver Diamine FluorideDrug

    Also called SDF

    Indirect pulp capping material

  • Glass IonomerDrug

    Also called GI

    Indirect pulp capping material

Study groups in NCT03568474
Study groupRoleWhat they receive
Silver Diamine FluorideExperimentalSilver Diamine fluoride will be applied after after minimal caries removal then glass ionomer over it followed by composite resin restoration.
Receives: Drug: Silver Diamine Fluoride; Drug: Glass Ionomer
Glass IonomerActive comparatorGlass ionomer will be applied after minimal caries removal followed by composite resin restoration.
Receives: Drug: Glass Ionomer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Pain

    Will be assessed by questioning the patient or the guardian whether there is postoperative pain or not, Binary (yes or no)

    Measured: 9 months

Secondary outcomes (4)
  1. Tooth vitality

    Will be assessed by Vitality test using thermal stimulation, binary (yes or no)

    Measured: 9 months

  2. Abscess

    Will be assessed intraoral Clinical examination whether there is swelling or not, binary (yes or no)

    Measured: 9 months

  3. Pain on percussion

    Will be assessed by Percussion test by using the back of the mirror on the tooth, binary (yes or no)

    Measured: 9 months

  4. Root lengthening

    Will be assessed measuring the root length by mm on the digital radiography (digora software)

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2018
  2. Study startOct 2018 (estimated)
  3. Primary completionOct 2019 (estimated)
  4. Study completionApr 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
parallel two arm groups with 1:1 allocation ratio
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03568474
Sponsor's protocol ID
Egypt Cairo University
Status last verified
Jun 2018
First submitted
4 Jun 2018
Last updated
26 Jun 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
Yes: thesis and article publication

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Silver Diamine Fluoride and Glass Ionomer in people with Deep Caries, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rehan Anwar, MSc (+201210339553, rehananwar28@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Pain (time frame: 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in